Project Grant R56DK135501
Award Date
8/19/24
Completion Date
8/31/25
Dollars Obligated
$410K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $120,792 to the University of Alabama at Birmingham (UAB) to conduct research on the role of glucagon-like peptide-1 receptor (GLP-1R) agonism in the central amygdala and its effects on appetite and food intake. The research aims to characterize the neural physiology of...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), funded under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $655,971 to investigate the pathophysiological role of the brain's endogenous glucagon-like peptide 1 (GLP-1) system in the development of diet-induced obesity. The key objectives of this 5-year research project are to: 1) use electrophysiological, anatomical, and optical...
This $800,000 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) to develop new combinatorial pharmacology approaches for regulating multiple neuron types in the brain to effectively promote satiety and reduce body weight in mouse models of obesity. The research aims to...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund research to understand the role of the protein ADGRL1 in the hypothalamus and its importance for the counterregulatory response to hypoglycemia. The $538,354 award, spanning June 2025 to March 2030, will be administered by the University of Kentucky Research Foundation. The research aims...
This $696,329 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research conducted by Virginia Polytechnic Institute & State University (Virginia Tech) to investigate sub-second catecholamine dynamics underlying food reward in humans. The research aims to measure dopamine and norepinephrine dynamics from the amygdala during food-based...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $176,500.00 to the University of Washington to investigate the links between hypothalamic microglia activation and perineuronal net (PNN) loss in the arcuate nucleus, and how these changes contribute to the pathogenesis of diet-induced obesity and glucose regulation. The...
This Project Grant award, totaling $502,233, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant, effective February 1, 2025 through November 30, 2029, supports research at the University of Michigan to study neuron populations in the nucleus of the solitary tract (NTS) that mediate the aversive and non-aversive suppression of food intake. The...
This Project Grant award, valued at $780,853 and awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program, supports research to investigate the impact of a glucagon-like peptide-1 (GLP-1) receptor agonist on HIV/SIV pathogenesis and antiretroviral therapy (ART) in a pigtailed macaque model. The research aims to assess changes in T-cell and macrophage metabolism, antiviral...
This Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to evaluate the therapeutic potential of a new orally active small molecule in obesity-linked diabetic models. The $418,560 award, with a start date of September 1, 2024 and an end date of April 30, 2025, will support research to analyze the pharmacokinetic profiles of the new small...
This federal Project Grant award of $293,604 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research to understand the role of the hypothalamic adhesion G-protein coupled receptor L 1 (ADGRL1) in counteracting hypoglycemia (dangerously low blood glucose levels). The primary research aims are to: 1) Establish the contribution of ADGRL1 in the ventromedial nucleus of the hypothalamus...